Premium
Letter: clarithromycin dose for H. pylori therapy remains unresolved – authors’ reply
Author(s) -
Sharara A. I.,
Harb A. H.,
Chalhoub J. M.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13323
Subject(s) - clarithromycin , medicine , confounding , randomized controlled trial , meta analysis , cure rate , subgroup analysis , intention to treat analysis , helicobacter pylori
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom